

Drug discovery
3
papers
On emerging therapies
Overview
Hereditary persistence of alpha-fetoprotein (HPAFP) is a rare, benign autosomal dominant condition characterized by lifelong elevated serum alpha-fetoprotein levels without associated pathology. It stems from AFP gene promoter mutations (particularly −119G>A) that enhance transcriptional activity [5][9][14]. Clinically significant as a differential diagnosis for unexplained AFP elevation, it requires family studies or genetic testing to avoid misdirected investigations for malignancies or liver diseases [1][6][16].